Lite Strategy, Inc. (LITS) vs Metagenomi Therapeutics, Inc. (MGX)

• Lite Strategy, Inc. LITS 1.01 ▲ +4.12%
• Metagenomi Therapeutics, Inc. MGX 0.70 ▼ −4.11%

Lite Strategy, Inc. and Metagenomi Therapeutics, Inc. are both Biotechnology companies. Lite Strategy, Inc. and Metagenomi Therapeutics, Inc. are of similar size ($29.6M and $27.6M). Lite Strategy, Inc. grew revenue faster over the last twelve months: 152.9% against −59.8%. Lite Strategy, Inc. has the higher net margin (0.00% vs −689.2%) and the lower return on invested capital (−115.9% vs 0.00%). Across the 16 metrics below, Lite Strategy, Inc. leads on 10 and Metagenomi Therapeutics, Inc. on 6.